期刊文献+

血管造瘘术后首次透析内瘘血流量与血管通路预后关系研究 被引量:1

Impact of initial blood flow on outcomes of vascular access in hemodialysis patients
下载PDF
导出
摘要 目的探讨血液透析患者中首次套管插入术后的血管通路内瘘流量(Qa)与血液通路使用寿命的关系。方法本研究是2005年1月-2013年12月进行的前瞻性随访观察研究。共60例病患者(36位男性)纳入本次研究,入选本研究的患者在2005年1月-2005年12月进行了首次通路手术,且持续进行随访。结果其中9例患者(15%)通路手术失败。手术后首次使用血管通路的平均使用时间为(1.8±1.2)个月,患者平均随访时间为(50.5±25.9)个月。共有25例患者病死亡,6例患者进行了肾移植手术。患者起始Qa值为(757.5±476.4)mL/min。初次插管时间与起始Qa无显著性关系。总共22患者(36.7%)起始Qa〈500 mL/min。糖尿病和人造血管是累积通畅率差的危险因素。结论起始Qa〈500 mL/min是血管初级通常率差的危险因素。 【Objective】To evaluate access flow(Qa) at the time of first cannulation and its relationship to the survival of vascular access in hemodialysis patients. 【Methods】We conducted a prospective observational study from January 2005 to December 2013. We enrolled 60 patients(36 men) who underwent the first access operation between January 2005 and December 2005 and were followed-up for surveillance. 【Results】Maturation failure occurred in nine patients(15%). Mean time to first use was 1.8±1.2 months after surgery. The patients were followed-up for a mean of 50.5±25.9 months. There were 25 deaths and six kidney transplants in patients with a functioning access.The initial Qa was 757.5±476.4 mL/min. A total of 22 of the 60 patients(36.7%) had an initial Qa〈500 mL/min. Diabetic status and use of a graft were risk factors for low cumulative patency.【Conclusions】InitialQa〈500 mL/min is a risk factor for poor primary patency.
作者 王琼 宋加荣
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第18期65-69,共5页 China Journal of Modern Medicine
关键词 透析 血管造瘘术 内瘘血流量 arteriovenous fistula hemodialysis vascular access flow rate
  • 相关文献

参考文献6

  • 1KUO PC, WU CC, CHEN WJ. An occult cause of hemodialysis vascular access dysfunction[J]. Renal failure, 2010, 32(8): 1016- 1018.
  • 2SANDS JJ. Vascular access monitoring improves outcomes [J]. Blood Purification, 2011, 23(1): 45-49.
  • 3ALLON M, ROBBIN ML, YOUNG C J, et al. Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes[J]. Clinical Journal of the American Society of Nephrology, 2013, 8(10): 1750-1755.
  • 4TONELLI M, WINKELMAYER WC, JINDAL KK, et al. The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients[J]. Kidney International, 2003, 64(1): 295-304.
  • 5LEE T, BARKER J, ALLON M. Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomes [J]. American Journal of Kidney Diseases, 2005, 46(3): 501-508.
  • 6SONG JH, PARK GH, LEE SY, et al. Effect of sodium balance and the combination of ultrafihration profile during sodium pro- filing hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances[J]. Journal of the American Soci- ety of Nephrology, 2005, 16(1): 237-246.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部